FNY Investment Advisers’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

FNY Investment Advisers’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,500	Closed	-$7K	–	795
2023 Q2	$7K	Sell	2,500 -2,500	-50%	-$7.44K	0.01%	348
2023 Q1	$12K	Buy	+5,000	New	+$10.3K	0.01%	325
2022 Q3	–	Sell	-1,500	Closed	-$1K	–	894
2022 Q2	$1K	Buy	+1,500	New	+$2.57K	﹤0.01%	660

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FNY Investment Advisers's GRTX Position: Q3 2023 in Review

FNY Investment Advisers sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 2,500 shares — an estimated $7K sold.

FNY Investment Advisers first reported a position in GRTX in Q2 2022 and held it in 3 quarters. The position peaked at $12K in Q1 2023. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

FNY Investment Advisers reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
FNY Investment Advisers sold 2,500 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $7K.
FNY Investment Advisers first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
FNY Investment Advisers's Galera Therapeutics, Inc. Common Stock position peaked at $12K in Q1 2023.
38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.